Navigation Links
Carnival Corporation & plc Reports Financial Impact of Itinerary Changes Responding to H1N1 Influenza Mexico Travel Advisory; Plans Rapid Return to Popular Mexican Ports
Date:5/18/2009

MIAMI, May 18 /PRNewswire-FirstCall/ -- Carnival Corporation & plc (NYSE/LSE: CCL; NYSE CUK) today announced a financial impact estimated at approximately $0.05 per share, the majority of which will be incurred in the second fiscal quarter of 2009, as a result of modifications to cruise itineraries for the six-week period ended June 15, in response to the U.S. Centers for Disease Control (CDC) recommendation against non-essential travel to Mexico.

The CDC lifted its recommendation against non-essential travel on May 15, allowing for ships to return to popular ports in Mexico's coastal resort areas. However, the potential remains for additional financial impact beyond June 15 which could range up to approximately $0.05 per share bringing the estimated total impact to $0.10 per share on full year 2009 results. The company will continue to monitor booking trends and provide updated guidance on its second quarter earnings call.

Three of the company's brands modified itineraries for 27 cruise ships - 16 for Carnival Cruise Lines, six for Princess Cruises and five for Holland America Line -- to avoid previously scheduled calls in Mexico. In many instances the modifications involved simply substituting another port while others required the development of entirely new itineraries. Princess' and Holland America's Mexico calls are seasonal and conclude this month while Carnival's are year-round.

"Our vessels are resuming their original itineraries as soon as practical but will all be back by the middle of June. The Mexican coastal resort areas where our ships call are some of the most popular destinations for North Americans vacationers. We know that our guests are looking forward to visiting Mexico and that they will have a safe and enjoyable experience there," said Micky Arison, chairman and CEO for Carnival Corporation & plc.

Only the Carnival Cruise Lines brand vessels will be impacted by the change in the CDC advisory. Gerry Cahill, president and CEO of that operating unit said, "Mexico has so many wonderful sites and attractions and feedback from our customers suggests that the majority support a resumption of port calls in Mexico. We know that they and our port destination partners are very much looking forward to our return."

A ship-by-ship listing including dates for when each Carnival Cruise Lines' vessel will resume its original itinerary is available at http://www.carnival.com/cms/fun/cruise_control/itinerary_updates.aspx

Carnival Corporation & plc is the largest cruise vacation group in the world, with a portfolio of cruise brands in North America, Europe and Australia, comprised of Carnival Cruise Lines, Holland America Line, Princess Cruises, The Yachts of Seabourn, AIDA Cruises, Costa Cruises, Cunard Line, Ibero Cruises, Ocean Village, P&O Cruises and P&O Cruises Australia.

Together, these brands operate 90 ships totaling more than 173,000 lower berths with 15 new ships scheduled to be delivered between May 2009 and June 2012. Carnival Corporation & plc also operates Holland America Tours and Princess Tours, the leading tour companies in Alaska and the Canadian Yukon. Traded on both the New York and London Stock Exchanges, Carnival Corporation & plc is the only group in the world to be included in both the S&P 500 and the FTSE 100 indices.


'/>"/>
SOURCE Carnival Corporation & plc
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Expectant Moms Offered Free Prenatal Prescription Vitamins at D-FW Area Carnival, Minyard and Sackn Save Stores
2. Mardi Gras Gives Everyone a Big Fat Break Because Carnival Means "So Long" to Meat
3. Mardi Gras Gives Everyone a Big Fat Break Because Carnival Means So Long to Meat
4. Wyclef Jean and Miri Ben-Ari to Lead Phoenix House Tribute to Lisa Ellis of Fireman Capital Partners and Carnival House Recordings
5. Carnival Cruise Lines to Resume Port Calls in Mexico
6. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
7. Brooke Franchise Corporation Announces Selected July Results
8. MedThink Communications Retained by NanoBio Corporation
9. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
10. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
11. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2017)... TX (PRWEB) , ... January 22, 2017 , ... ... provide slow results. Often the results of a simple test will take days to ... Any Lab Test Now offers customers direct access to their lab tests, bypassing the ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... Phytocéane ... Indian Ocean, isolated from the rest of the world with ZANZIBAR SHOWER GEL. Inspired ... Phytocéane used key ingredients, Virgin Coconut Oil and moisturizing vegetal coral to create this ...
(Date:1/21/2017)... ... January 21, 2017 , ... The Nobel ... Dan Holtzclaw in media for its creos™ line of bone regenerative products. ... Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for a variety of ...
(Date:1/20/2017)... , ... January 20, 2017 , ... Doctor C LLC, ... attended the January ECRM trade show to continue the marketing and distribution of its ... supplement, known for providing 400 percent better absorption than traditional vitamin C supplements. At ...
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser celebrated 5 years ... Betsy, the clinical trial has been life-saving as she has been on the ... Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent standard chemotherapy but ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... 2017 ResMed (NYSE: RMD ), BMC ( ... Haven, Florida ) today announced they have agreed on a ... will be permitted to sell their existing products in exchange for ... payment to 3B to close the Florida ... admission of liability or wrongdoing by any party. ...
(Date:1/21/2017)... , Jan. 20, 2017 ARMO BioSciences, Inc., ... data on the Company,s lead investigational immuno-oncology drug AM0010 ... by the American Society of Clinical Oncology (ASCO), taking ... CA. "AM0010 induces the ... + T cells in the blood and tumors ...
(Date:1/21/2017)... -- Research and Markets has announced the addition of ... Route Of Administration, End User - Forecast to 2025" report ... ... a CAGR of around 7.8% over the next decade to reach ... analyzes the global markets for Advanced Drug Delivery across all the ...
Breaking Medicine Technology: